Birdwatch Note
2024-05-27 01:11:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
chromeで開き右クリックで翻訳するとわかりますがこの記事が摘示したのは「米国政府がコロナワクチンや検査の促進等を目的として数十億の契約を大手薬局会社とした」という内容にすぎず契約内容にはイベルメクチンという単語は登場しません https://www.americaoutloud.news/the-government-cartel-paid-billions-to-walgreens-and-cvs-not-to-fill-ivermectin-the-question-is-why/ イベルメクチンは日本の2つのランダム化比較試験(RCT)でも https://www.kowa.co.jp/news/2022/press20220926.html https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 世界のRCTのメタ解析でも臨床アウトカムの改善への有効性は見だせていません https://academic.oup.com/cid/article/74/6/1022/6310839?login=false https://journals.lww.com/aptm/Fulltext/2023/16010/Efficacy_and_safety_of_ivermectin_in_patients_with.2.aspx これはRCTで有効性を見だし早々と承認された安価なデキサメタゾン↓等と対照的で https://dm-rg.net/news/2020/07/020449.html 臨床試験で有効性が見だせなかった薬は一般に承認されないという単純な事実に注意が必要です
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1794873651462074705
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1794899209579380970
- noteId - 1794899209579380970
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1716772293834
- tweetId - 1794873651462074705
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- chromeで開き右クリックで翻訳するとわかりますがこの記事が摘示したのは「米国政府がコロナワクチンや検査の促進等を目的として数十億の契約を大手薬局会社とした」という内容にすぎず契約内容にはイベルメクチンという単語は登場しません https://www.americaoutloud.news/the-government-cartel-paid-billions-to-walgreens-and-cvs-not-to-fill-ivermectin-the-question-is-why/ イベルメクチンは日本の2つのランダム化比較試験(RCT)でも https://www.kowa.co.jp/news/2022/press20220926.html https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 世界のRCTのメタ解析でも臨床アウトカムの改善への有効性は見だせていません https://academic.oup.com/cid/article/74/6/1022/6310839?login=false https://journals.lww.com/aptm/Fulltext/2023/16010/Efficacy_and_safety_of_ivermectin_in_patients_with.2.aspx これはRCTで有効性を見だし早々と承認された安価なデキサメタゾン↓等と対照的で https://dm-rg.net/news/2020/07/020449.html 臨床試験で有効性が見だせなかった薬は一般に承認されないという単純な事実に注意が必要です
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-27 01:11:33 UTC (1716772293834) |
2024-05-27 10:03:16 UTC (1716804196789) |
CURRENTLY_RATED_HELPFUL | 2024-05-28 09:05:06 UTC (1716887106190) |
NEEDS_MORE_RATINGS | 2024-05-27 10:03:16 UTC (1716804196789) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-27 19:11:35 -0500 | Rating Details | |
2024-05-27 18:18:02 -0500 | Rating Details | |
2024-05-27 15:15:20 -0500 | Rating Details | |
2024-05-27 07:43:50 -0500 | Rating Details | |
2024-05-27 06:20:17 -0500 | Rating Details | |
2024-05-27 05:35:07 -0500 | Rating Details | |
2024-05-27 01:30:21 -0500 | Rating Details | |
2024-05-27 01:04:23 -0500 | Rating Details | |
2024-05-27 00:44:12 -0500 | Rating Details | |
2024-05-27 00:24:18 -0500 | Rating Details | |
2024-05-27 00:01:49 -0500 | Rating Details | |
2024-05-27 00:01:07 -0500 | Rating Details | |
2024-05-26 23:39:34 -0500 | Rating Details | |
2024-05-26 23:23:56 -0500 | Rating Details | |
2024-05-26 23:00:46 -0500 | Rating Details | |
2024-05-26 21:52:53 -0500 | Rating Details | |
2024-05-26 21:17:58 -0500 | Rating Details | |
2024-05-26 21:08:31 -0500 | Rating Details | |
2024-05-26 21:06:03 -0500 | Rating Details | |
2024-05-26 20:47:42 -0500 | Rating Details | |
2024-05-26 20:44:00 -0500 | Rating Details | |
2024-05-26 20:41:48 -0500 | Rating Details | |
2024-05-26 20:33:16 -0500 | Rating Details | |
2024-05-28 16:24:39 -0500 | Rating Details | |
2024-05-28 15:04:29 -0500 | Rating Details | |
2024-05-28 09:44:42 -0500 | Rating Details | |
2024-05-27 17:41:44 -0500 | Rating Details | |
2024-05-27 15:20:11 -0500 | Rating Details | |
2024-05-27 15:09:50 -0500 | Rating Details | |
2024-05-27 15:07:39 -0500 | Rating Details | |
2024-05-27 14:59:48 -0500 | Rating Details | |
2024-05-27 10:07:17 -0500 | Rating Details | |
2024-05-27 01:57:49 -0500 | Rating Details | |
2024-05-27 01:45:14 -0500 | Rating Details | |
2024-05-27 01:31:02 -0500 | Rating Details | |
2024-05-27 00:03:55 -0500 | Rating Details | |
2024-05-26 23:38:55 -0500 | Rating Details | |
2024-05-26 23:29:35 -0500 | Rating Details | |
2024-05-26 23:07:50 -0500 | Rating Details | |
2024-05-26 22:18:41 -0500 | Rating Details | |
2024-05-26 21:51:15 -0500 | Rating Details | |
2024-05-26 21:39:38 -0500 | Rating Details | |
2024-05-26 21:38:20 -0500 | Rating Details | |
2024-05-26 21:34:51 -0500 | Rating Details | |
2024-05-26 21:21:30 -0500 | Rating Details | |
2024-05-26 21:15:10 -0500 | Rating Details | |
2024-05-26 20:47:48 -0500 | Rating Details | |
2024-05-26 20:47:04 -0500 | Rating Details | |
2024-05-26 20:40:09 -0500 | Rating Details | |
2024-05-26 20:39:49 -0500 | Rating Details | |
2024-05-26 20:35:16 -0500 | Rating Details | |
2024-05-26 20:34:32 -0500 | Rating Details | |
2024-05-26 20:22:47 -0500 | Rating Details | |
2024-05-26 20:22:31 -0500 | Rating Details | |
2024-05-26 20:19:35 -0500 | Rating Details | |
2024-05-29 17:53:24 -0500 | Rating Details | |
2024-05-31 19:12:19 -0500 | Rating Details | |
2024-05-27 22:17:28 -0500 | Rating Details | |
2024-05-27 16:58:07 -0500 | Rating Details | |
2024-05-27 15:25:47 -0500 | Rating Details | |
2024-05-27 15:02:46 -0500 | Rating Details | |
2024-05-27 14:46:59 -0500 | Rating Details | |
2024-05-27 04:03:32 -0500 | Rating Details | |
2024-05-27 01:53:50 -0500 | Rating Details | |
2024-05-27 01:16:45 -0500 | Rating Details | |
2024-05-27 01:14:11 -0500 | Rating Details | |
2024-05-26 23:58:34 -0500 | Rating Details | |
2024-05-26 23:54:32 -0500 | Rating Details | |
2024-05-26 23:08:33 -0500 | Rating Details | |
2024-05-26 22:52:14 -0500 | Rating Details | |
2024-05-26 22:27:58 -0500 | Rating Details | |
2024-05-26 22:11:41 -0500 | Rating Details | |
2024-05-26 22:10:03 -0500 | Rating Details | |
2024-05-26 22:01:48 -0500 | Rating Details | |
2024-05-26 21:08:44 -0500 | Rating Details | |
2024-05-26 21:06:36 -0500 | Rating Details | |
2024-05-26 20:53:35 -0500 | Rating Details | |
2024-05-26 20:51:24 -0500 | Rating Details | |
2024-05-26 20:36:55 -0500 | Rating Details | |
2024-05-26 20:30:34 -0500 | Rating Details | |
2024-05-26 20:29:34 -0500 | Rating Details | |
2024-05-26 20:25:18 -0500 | Rating Details | |
2024-05-26 20:23:28 -0500 | Rating Details | |
2024-05-26 20:15:57 -0500 | Rating Details | |
2024-06-04 02:18:46 -0500 | Rating Details | |
2024-06-02 07:42:05 -0500 | Rating Details |